Altimmune rises as buyout rumors follow R&D updates Mar. 14, 2025 2:13 PM ET Altimmune, Inc. (ALT) Stock By: Dulan Lokuwithana , SA News Editor 10 Comments Play ( 1min ) ...

Shares of Altimmune Inc. are down more than 23% this year, but that has not deterred retail investors from losing hope in the clinical-stage biotech company. The company has gained traction for ...